Free Trial
→ In 30 days, you'll wish you'd read this email (From Behind the Markets) (Ad)tc pixel Free FMS Stock Alerts

Fresenius Medical Care AG & Co. KGaA (FMS) Competitors

Fresenius Medical Care AG & Co. KGaA logo
$20.90 +0.35 (+1.68%)
Closing price 06/3/2026 03:58 PM Eastern
Extended Trading
$21.58 +0.68 (+3.28%)
As of 07:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

FMS vs. NTRA, GH, BTSG, CELC, and PACS

Should you buy Fresenius Medical Care AG & Co. KGaA stock or one of its competitors? MarketBeat compares Fresenius Medical Care AG & Co. KGaA with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Fresenius Medical Care AG & Co. KGaA include Natera (NTRA), Guardant Health (GH), BrightSpring Health Services (BTSG), Celcuity (CELC), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Fresenius Medical Care AG & Co. KGaA compare to Natera?

Natera (NASDAQ:NTRA) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, risk, earnings, valuation, analyst recommendations, media sentiment, dividends and institutional ownership.

99.9% of Natera shares are owned by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 5.1% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natera$2.31B13.16-$208.16M-$1.63N/A
Fresenius Medical Care AG & Co. KGaA$22.20B0.51$1.11B$1.9011.00

In the previous week, Natera had 25 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 27 mentions for Natera and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Natera's average media sentiment score of 1.11 beat Fresenius Medical Care AG & Co. KGaA's score of -0.04 indicating that Natera is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Natera
16 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Natera has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Natera's net margin of -9.05%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
Natera-9.05% -14.74% -10.27%
Fresenius Medical Care AG & Co. KGaA 4.88%8.90%4.05%

Natera presently has a consensus target price of $256.81, indicating a potential upside of 21.22%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, indicating a potential upside of 34.00%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Natera.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natera
1 Sell rating(s)
3 Hold rating(s)
14 Buy rating(s)
2 Strong Buy rating(s)
2.85
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44

Summary

Natera beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Guardant Health?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Guardant Health (NASDAQ:GH) are both large-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings.

In the previous week, Guardant Health had 11 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 13 mentions for Guardant Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Guardant Health's average media sentiment score of 0.28 beat Fresenius Medical Care AG & Co. KGaA's score of -0.04 indicating that Guardant Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Guardant Health
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.51$1.11B$1.9011.00
Guardant Health$982.02M17.15-$416.28M-$3.39N/A

Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market. Comparatively, Guardant Health has a beta of 1.61, suggesting that its share price is 61% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Guardant Health's net margin of -40.10%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
Guardant Health -40.10%N/A -26.42%

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $28.00, indicating a potential upside of 34.00%. Guardant Health has a consensus price target of $136.37, indicating a potential upside of 7.35%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Guardant Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
19 Buy rating(s)
1 Strong Buy rating(s)
2.95

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Guardant Health beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both large-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, analyst recommendations, profitability, institutional ownership and valuation.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than BrightSpring Health Services. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B0.91$190.67M$1.4143.18
Fresenius Medical Care AG & Co. KGaA$22.20B0.51$1.11B$1.9011.00

BrightSpring Health Services presently has a consensus price target of $57.64, indicating a potential downside of 5.32%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $28.00, indicating a potential upside of 34.00%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.12
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to BrightSpring Health Services' net margin of 2.27%. BrightSpring Health Services' return on equity of 14.63% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.27% 14.63% 4.41%
Fresenius Medical Care AG & Co. KGaA 4.88%8.90%4.05%

BrightSpring Health Services has a beta of 1.87, suggesting that its stock price is 87% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, suggesting that its stock price is 20% less volatile than the broader market.

In the previous week, BrightSpring Health Services had 2 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 4 mentions for BrightSpring Health Services and 2 mentions for Fresenius Medical Care AG & Co. KGaA. BrightSpring Health Services' average media sentiment score of 1.15 beat Fresenius Medical Care AG & Co. KGaA's score of -0.04 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

BrightSpring Health Services beats Fresenius Medical Care AG & Co. KGaA on 11 of the 17 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to Celcuity?

Celcuity (NASDAQ:CELC) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, risk, analyst recommendations, earnings, dividends, media sentiment, profitability and institutional ownership.

In the previous week, Celcuity had 22 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 24 mentions for Celcuity and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of -0.04 beat Celcuity's score of -0.13 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Celcuity
3 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
4 Very Negative mention(s)
Neutral
Fresenius Medical Care AG & Co. KGaA
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CelcuityN/AN/A-$177.04M-$3.90N/A
Fresenius Medical Care AG & Co. KGaA$22.20B0.51$1.11B$1.9011.00

Celcuity has a beta of 0.1, meaning that its stock price is 90% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.8, meaning that its stock price is 20% less volatile than the broader market.

63.3% of Celcuity shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 13.3% of Celcuity shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Celcuity's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Celcuity's return on equity.

Company Net Margins Return on Equity Return on Assets
CelcuityN/A -244.61% -50.22%
Fresenius Medical Care AG & Co. KGaA 4.88%8.90%4.05%

Celcuity currently has a consensus price target of $152.09, indicating a potential upside of 70.98%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $28.00, indicating a potential upside of 34.00%. Given Celcuity's stronger consensus rating and higher possible upside, research analysts clearly believe Celcuity is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Celcuity
1 Sell rating(s)
0 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.83
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44

Summary

Fresenius Medical Care AG & Co. KGaA beats Celcuity on 9 of the 15 factors compared between the two stocks.

How does Fresenius Medical Care AG & Co. KGaA compare to PACS Group?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and PACS Group (NYSE:PACS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to PACS Group's net margin of 4.49%. PACS Group's return on equity of 26.47% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
PACS Group 4.49%26.47%4.36%

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $28.00, suggesting a potential upside of 34.00%. PACS Group has a consensus price target of $48.00, suggesting a potential upside of 31.55%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, research analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.44
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than PACS Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.51$1.11B$1.9011.00
PACS Group$5.29B1.09$191.54M$1.5623.39

In the previous week, Fresenius Medical Care AG & Co. KGaA had 1 more articles in the media than PACS Group. MarketBeat recorded 2 mentions for Fresenius Medical Care AG & Co. KGaA and 1 mentions for PACS Group. PACS Group's average media sentiment score of 0.00 beat Fresenius Medical Care AG & Co. KGaA's score of -0.04 indicating that PACS Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
PACS Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

PACS Group beats Fresenius Medical Care AG & Co. KGaA on 8 of the 15 factors compared between the two stocks.

Get Fresenius Medical Care AG & Co. KGaA News Delivered to You Automatically

Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding FMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FMS vs. The Competition

Export
MetricFresenius Medical Care AG & Co. KGaAMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$11.10B$7.25B$6.47B$23.28B
Dividend Yield2.95%1.23%2.69%4.06%
P/E Ratio11.0045.0622.1731.00
Price / Sales0.5174.02524.0123.82
Price / Cash3.6924.2241.3424.93
Price / Book0.727.159.784.67
Net Income$1.11B$159.22M$3.57B$1.07B
7 Day Performance-3.55%-2.00%-2.50%-1.10%
1 Month PerformanceN/AN/AN/A0.25%
1 Year Performance-26.01%0.95%26.49%25.20%

Fresenius Medical Care AG & Co. KGaA Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FMS
Fresenius Medical Care AG & Co. KGaA
4.669 of 5 stars		$20.90
+1.7%		$28.00
+34.0%		-26.3%$11.10B$22.20B11.001,488
NTRA
Natera
4.3236 of 5 stars		$203.19
flat		$256.60
+26.3%		+32.3%$29.10B$2.31BN/A6,140
GH
Guardant Health
2.1177 of 5 stars		$118.95
flat		$129.00
+8.4%		+177.4%$15.77B$982.02MN/A2,506
BTSG
BrightSpring Health Services
4.2859 of 5 stars		$58.50
flat		$57.00
-2.6%		+157.4%$11.34B$12.91B41.4923,500
CELC
Celcuity
2.9463 of 5 stars		$138.23
flat		$149.30
+8.0%		+645.0%$6.74BN/AN/A40

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:FMS) was last updated on 6/4/2026 by MarketBeat.com Staff.
From Our Partners
A gold storm is coming – are you ready?
The U.S. Treasury Secretary is betting big on gold - and the world's most successful investors are following s...
Traders Agency | Sponsoredtc pixel
The SpaceX S-1 changes everything
SpaceX just filed its IPO paperwork. And buried inside that filing was something that should change how every ...
Crypto 101 Media | Sponsoredtc pixel
Trump’s New Dollar revealed
The last time something like this happened was 1974 - a secret deal that quietly determined the financial fate...
Porter & Company | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
How to claim a stake in SpaceX before the June 12 IPO
SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...
Brownstone Research | Sponsoredtc pixel
Oil is settling in yuan now - here's what that means for gold
Saudi Arabia has terminated its 1974 petrodollar agreement with the United States - the deal that forced every...
Golden Portfolio | Sponsoredtc pixel
The chokepoint supplier behind SpaceX's $1.75 trillion empire
When Musk laughed and said 'you need transformers to run transformers,' it wasn't a joke - it was a confession...
Behind the Markets | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel